Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/105196
DC FieldValueLanguage
dc.contributor.authorDa Veiga Leal, Silvania-
dc.contributor.authorWard, Daniel-
dc.contributor.authorCampino, Susana-
dc.contributor.authorBenavente, Ernest Diez-
dc.contributor.authorIbrahim, Amy-
dc.contributor.authorClaret, Tânia-
dc.contributor.authorIsaías, Varela-
dc.contributor.authorMonteiro, Davidson-
dc.contributor.authorClark, Taane G-
dc.contributor.authorGonçalves, Luzia-
dc.contributor.authorValdez, Tomas-
dc.contributor.authorda Luz Lima Mendonça, Maria-
dc.contributor.authorSilveira, Henrique-
dc.contributor.authorNogueira, Fátima-
dc.date.accessioned2023-02-08T11:52:07Z-
dc.date.available2023-02-08T11:52:07Z-
dc.date.issued2021-03-31-
dc.identifier.issn1475-2875pt
dc.identifier.urihttps://hdl.handle.net/10316/105196-
dc.description.abstractCape Verde is an archipelago located off the West African coast and is in a pre-elimination phase of malaria control. Since 2010, fewer than 20 Plasmodium falciparum malaria cases have been reported annually, except in 2017, when an outbreak in Praia before the rainy season led to 423 autochthonous cases. It is important to understand the genetic diversity of circulating P. falciparum to inform on drug resistance, potential transmission networks and sources of infection, including parasite importation. Methods: Enrolled subjects involved malaria patients admitted to Dr Agostinho Neto Hospital at Praia city, Santiago island, Cape Verde, between July and October 2017. Neighbours and family members of enrolled cases were assessed for the presence of anti-P. falciparum antibodies. Sanger sequencing and real-time PCR was used to identify SNPs in genes associated with drug resistance (e.g., pfdhfr, pfdhps, pfmdr1, pfk13, pfcrt), and whole genome sequencing data were generated to investigate the population structure of P. falciparum parasites. Results: The study analysed 190 parasite samples, 187 indigenous and 3 from imported infections. Malaria cases were distributed throughout Praia city. There were no cases of severe malaria and all patients had an adequate clinical and parasitological response after treatment. Anti-P. falciparum antibodies were not detected in the 137 neighbours and family members tested. No mutations were detected in pfdhps. The triple mutation S108N/N51I/C59R in pfdhfr and the chloroquine-resistant CVIET haplotype in the pfcrt gene were detected in almost all samples. Variations in pfk13 were identified in only one sample (R645T, E668K). The haplotype NFD for pfmdr1 was detected in the majority of samples (89.7%). Conclusions: Polymorphisms in pfk13 associated with artemisinin-based combination therapy (ACT) tolerance in Southeast Asia were not detected, but the majority of the tested samples carried the pfmdr1 haplotype NFD and anti-malarial-associated mutations in the the pfcrt and pfdhfr genes. The first whole genome sequencing (WGS) was performed for Cape Verdean parasites that showed that the samples cluster together, have a very high level of similarity and are close to other parasites populations from West Africa.pt
dc.language.isoengpt
dc.publisherSpringer Naturept
dc.relationNational Institute of Public Health through Government of Cape Verde funds to 65.06.01.04.37-Promoçao Da Capacidade Institucional e Tecnica Do INSPpt
dc.relationUID/04413/2020pt
dc.relationMRC UK (Grant no. MC_PC_15103, MR/K000551/1, MR/M01360X/1, MR/N010469/1, MR/R020973/1) and BBSRC UK (BB/R013063/1)pt
dc.relationMedical Research Council UK grants (MC_PC_15103, MR/R020973/1) and the BBSRC UK (BB/R013063/1)pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectDrug resistancept
dc.subjectGeneticspt
dc.subjectMalariapt
dc.subjectPlasmodium falciparumpt
dc.subjectSequencingpt
dc.subject.meshAdolescentpt
dc.subject.meshAdultpt
dc.subject.meshAgedpt
dc.subject.meshAged, 80 and overpt
dc.subject.meshAntimalarialspt
dc.subject.meshCabo Verdept
dc.subject.meshChildpt
dc.subject.meshChild, Preschoolpt
dc.subject.meshDisease Outbreakspt
dc.subject.meshDrug Resistancept
dc.subject.meshFemalept
dc.subject.meshHumanspt
dc.subject.meshMalaria, Falciparumpt
dc.subject.meshMalept
dc.subject.meshMiddle Agedpt
dc.subject.meshPlasmodium falciparumpt
dc.subject.meshProtozoan Proteinspt
dc.subject.meshYoung Adultpt
dc.subject.meshPolymorphism, Geneticpt
dc.titleDrug resistance profile and clonality of Plasmodium falciparum parasites in Cape Verde: the 2017 malaria outbreakpt
dc.typearticle-
degois.publication.firstPage172pt
degois.publication.issue1pt
degois.publication.titleMalaria Journalpt
dc.peerreviewedyespt
dc.identifier.doi10.1186/s12936-021-03708-zpt
degois.publication.volume20pt
dc.date.embargo2021-03-31*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais
Show simple item record

SCOPUSTM   
Citations

4
checked on Apr 29, 2024

WEB OF SCIENCETM
Citations

4
checked on May 2, 2024

Page view(s)

39
checked on May 7, 2024

Download(s)

26
checked on May 7, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons